Video Abstract.mp4 (34.78 MB)

Laboratory Safety of Dupilumab in Patients Aged 6 to 11 Years with Severe Atopic Dermatitis: Results from a Phase 3 Clinical Trial

Version 2 2021-08-03, 02:15

Version 1 2021-07-15, 22:11

media

posted on 2021-08-03, 02:15 authored by Amy S. Paller, Andreas Wollenberg, Elaine Siegfried, Diamant Thaçi, Michael J. Cork, Peter D. Arkwright, Melinda Gooderham, Xian Sun, John O’Malley, Faisal A. Khokhar, Jignesh Vakil, Ashish Bansal, Karli Rosner, Brad Shumel, Noah A. Levit

For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).